44% of healthcare organizations open 3+ patient records at once

About half of healthcare organizations report opening three or more patient records within electronic health records (EHRs) at a time, increasing the likelihood these files can become infected if the platform is not protected, according to a study published in the Journal of the American Medical Informatics Association.

Ensuring the safety of patient information within EHRs requires healthcare professionals follow recommendations on safety procedures. One of those procedures is to limit the amount of patient records open at once, but whether these guidelines are followed is not known. This study analyzed two nation listservs to conduct a survey on EHR practices in 167 inpatient and outpatient facilities using EHR systems designed to open more than one record at a time.

Results showed that 44.3 percent of facilities had EHR systems configured to allow more than three records at a time, and 38.3 percent allowed for only one record to be open and 17.4 percent allowed for two to be opened.

“Decision-making centered on efforts to balance safety and efficiency, but there was disagreement among organizations about how to achieve that balance,” wrote lead author Jason S. Adelman, MD, and colleagues. “Results demonstrate no consensus on the number of records to be allowed open at once in EHRs. Rigorous studies are needed to determine the optimal number of records that balances safety and efficiency.”

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.